Assessment of Sense of Identity in Patients Diagnosed With Borderline Personality Disorder. A Pilot Study (MASB)

January 2, 2023 updated by: Centre Hospitalier Universitaire de Nīmes

Assessment of Sense of Identity in Patients With a Diagnosis of Borderline Personality Disorder Through Autobiographical Memory and the Contents of Self-defining Memories, Compared to a Group of Healthy Individuals. A Pilot Study

One of the key features and long considered a fundamental element of Borderline Personality Disorder is the disruption of identity. Autobiographical memory is closely linked to the development and maintenance of a coherent, stable sense of self. It enables the individual to understand who he or she is. The investigators hypothesize that individuals diagnosed with Borderline Personality Disorder have a less coherent, stable sense of the self than healthy controls. The aim of the study is therefore to compare the sense of identity between a group of patients diagnosed with Borderline Personality Disorder and a group of healthy individuals (without Borderline Personality Disorder ).

This can be measured by evaluating the content of the self-defining memory using the Self-Defining Memory scale.

Study Overview

Study Type

Observational

Enrollment (Actual)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gard
      • Nîmes, Gard, France, 30029
        • Nîmes University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

30 patients diagnosed as having Bordeline Personality Disorder 30 healthy controls recruited from a poster Campaign within the various departments of Nîmes University Hospital, France.

Description

Inclusion Criteria:

  • Subject must have given written consent
  • Subject affiliated or beneficiary of a health insurance plan.
  • Adult subjects between 25 and 55 years of age
  • Oral and written mastery of the French language

Inclusion criteria for the borderline group:

  • Subject diagnosed as having borderline personality disorder according to the DSM IV classification

Exclusion criteria for the borderline group:

  • Patients without diagnosis of borderline personality disorder according to the DSM IV classification after taking the SCID II (Structured Clinical Interview for DSM-III-R Axis II Disorders) test

Exclusion criteria for the control group:

  • Subjects considered Borderline after taking the SCID II (Structured Clinical Interview for DSM-III-R Axis II Disorders) test
  • Subjects with a score above 8 on the HADS questionnaire corresponding to questionable symptomatology for anxiety and depressive symptoms.

General exclusion Criteria:

  • Subjects under court protection, guardianship or curatorship
  • Subjects for whom it is impossible to give informed information
  • Subjects participating in a Category 1 or 2 RIPH in the 3 months prior to the study
  • Subject refusing to give written consent
  • Presence of known neurological disease
  • Pregnant or breastfeeding women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients diagnosed as having Borderline Personality Disorder
These patients have been diagnosed as having Borderline Personality Disorder according to the Diagnostic and Statistical Manual IV classification after taking the Structured Clinical Interview for DSM-IV Axis I Disorders test.

This questionnaire consists of 3 pages. Page 1 gives a clear, concise definition of a memory that defines the self. This enlightens the subject on what is expected and helps him/her consider the phenomenological characteristics of the Self-Defining Memory. Page 2 recalls the 6 essential characteristics of the Self-Defining Memory. Page 3 allows the practical application of what has been understood about the questionnaire. At least 3 memories are asked of the participants. Each memory is rated as follows : On a scale of 0 - 6 for each of the following emotions, participants note how they feel when recalling each memory. Happy, Sad, Angry, Fearful, Surprised, Ashamed,Disgusted,Guilty, Interested, Embarrassed, Contemptful, Proud. 0 = not at all, 3 = Moderately and 6 = Extremely.

Participants must then use the same scale to indicate the vividness and importance of the memory.

They must also note the approximate number of years ago the memory took place (to the nearest whole number).

Healthy Controls (Patients not diagnosed as having Borderline Personality Disorder )
These patients have NOT been diagnosed as having Borderline Personality Disorder according to the Diagnostic and Statistical Manual IV classification after taking the Structured Clinical Interview for DSM-IV Axis I Disorders test.

This questionnaire consists of 3 pages. Page 1 gives a clear, concise definition of a memory that defines the self. This enlightens the subject on what is expected and helps him/her consider the phenomenological characteristics of the Self-Defining Memory. Page 2 recalls the 6 essential characteristics of the Self-Defining Memory. Page 3 allows the practical application of what has been understood about the questionnaire. At least 3 memories are asked of the participants. Each memory is rated as follows : On a scale of 0 - 6 for each of the following emotions, participants note how they feel when recalling each memory. Happy, Sad, Angry, Fearful, Surprised, Ashamed,Disgusted,Guilty, Interested, Embarrassed, Contemptful, Proud. 0 = not at all, 3 = Moderately and 6 = Extremely.

Participants must then use the same scale to indicate the vividness and importance of the memory.

They must also note the approximate number of years ago the memory took place (to the nearest whole number).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sense of Identity in patients diagnosed with Borderline Personality Disorder according to the results of the Self-Defining Memory questionnaire.
Time Frame: Day 7

The answers to the Self-Defining Memory questionnaire will be analyzed. At least 3 memories are asked of the participants. Each memory is rated as follows : On a scale of 0 - 6 for each of the following emotions, participants note how they feel when recalling each memory. Happy, Sad, Angry, Fearful, Surprised, Ashamed,Disgusted,Guilty, Interested, Embarrassed, Contemptful, Proud. 0 = not at all, 3 = Moderately and 6 = Extremely.

Participants must then use the same scale to indicate the vividness and importance of the memory.

They must also note the approximate number of years ago the memory took place (to the nearest whole number).

Day 7
Sense of Identity in healthy controls according to the results of the Self-Defining Memory questionnaire.
Time Frame: Day 7

The answers to the Self-Defining Memory questionnaire will be analyzed. At least 3 memories are asked of the participants. Each memory is rated as follows : On a scale of 0 - 6 for each of the following emotions, participants note how they feel when recalling each memory. Happy, Sad, Angry, Fearful, Surprised, Ashamed,Disgusted,Guilty, Interested, Embarrassed, Contemptful, Proud. 0 = not at all, 3 = Moderately and 6 = Extremely.

Participants must then use the same scale to indicate the vividness and importance of the memory.

They must also note the approximate number of years ago the memory took place (to the nearest whole number).

Day 7

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-coherence of self-defining memories in patients diagnosed with Borderline Personality Disorder
Time Frame: Day 7

The TALE (Thinking About Life Experiences) self-questionnaire will be used to evaluate this point. This questionnaire contains 15 items, each to be answered with a 5-point Lickert scale (1 = almost never, 5 = very frequently) with the aim of measuring 3 theoretical functions found in the autobiographic memory:

  • The self-continuity function
  • The social bonding function
  • The directing behavior function
Day 7
Self-coherence of self-defining memories in healthy controls
Time Frame: Day 7

The TALE (Thinking About Life Experiences) self-questionnaire will be used to evaluate this point. This questionnaire contains 15 items, each to be answered with a 5-point Lickert scale (1 = almost never, 5 = very frequently) with the aim of measuring 3 theoretical functions found in the autobiographic memory:

  • The self-continuity function
  • The social bonding function
  • The directing behavior function
Day 7
Phenomenological details of self-defining memories in patients diagnosed with Borderline Personality Disorder
Time Frame: Day 7

The Memory Characteristics Questionnaire (MCQ) will be used to compare the self-defining memories in each group of patients, Borderline vs. Controls. The MCQ is a self-administered questionnaire for the assessment of phenomenological characteristics of autobiographical memory.

This measurement tool, comprising 15 items and constructed according to a 7-point Likert scale, can distinguish between memories of events, which contain more sensory and contextual details, from memories of contextual details, from memories of imagined events, which contain more elements relating to cognitive operations.

Day 7
Phenomenological details of self-defining memories in healthy controls
Time Frame: Day 7

The Memory Characteristics Questionnaire (MCQ) will be used to compare the self-defining memories in each group of patients, Borderline vs. Controls. The MCQ is a self-administered questionnaire for the assessment of phenomenological characteristics of autobiographical memory.

This measurement tool, comprising 15 items and constructed according to a 7-point Likert scale, can distinguish between memories of events, which contain more sensory and contextual details, from memories of contextual details, from memories of imagined events, which contain more elements relating to cognitive operations.

Day 7
Traumas undergone in patients diagnosed with Borderline Personality Disorder: Frequency
Time Frame: Day 7

The Childhood Trauma Questionnaire (CTQ) will be used to evaluate the frequency of traumas undergone by the patient.

The CTQ is a self-administered questionnaire of childhood and adolescent abuse. The short version, validated in French by David P Bernstein in 2003, includes 28 items and gives a quantitative estimate of the severity of maltreatment experienced. This self-administered questionnaire is based on a 5-point Likert scale and covers five main dimensions of abuse: physical abuse, sexual abuse, emotional abuse, physical neglect and emotional neglect.

Day 7
Traumas undergone in healthy controls: Frequency
Time Frame: Day 7

The Childhood Trauma Questionnaire (CTQ) will be used to evaluate the frequency of traumas undergone by healthy controls.

The CTQ is a self-administered questionnaire of childhood and adolescent abuse. The short version, validated in French (David P Bernstein et al. 2003), includes 28 items and gives a quantitative estimate of the severity of maltreatment experienced. This self-administered questionnaire is based on a 5-point Likert scale and covers five main dimensions of abuse: physical abuse, sexual abuse, emotional abuse, physical neglect and emotional neglect.

Day 7
Traumas undergone in patients diagnosed with Borderline Personality Disorder: Type
Time Frame: Day 7

The Childhood Trauma Questionnaire (CTQ) will be used to evaluate the type of traumas undergone by the patient.

The CTQ is a self-administered questionnaire of childhood and adolescent abuse. The short version, validated in French, includes 28 items and gives a quantitative estimate of the severity of maltreatment experienced. This self-administered questionnaire is based on a 5-point Likert scale and covers five main dimensions of abuse: physical abuse, sexual abuse, emotional abuse, physical neglect and emotional neglect.

Day 7
Traumas undergone in healthy controls: Type
Time Frame: Day 7
The Childhood Trauma Questionnaire (CTQ) will be used to evaluate the type of traumas undergone in healthy controls: The CTQ is a self-administered questionnaire of childhood and adolescent abuse. The short version, validated in French by David P Bernstein in 2003, includes 28 items and gives a quantitative estimate of the severity of maltreatment experienced. This self-administered questionnaire is based on a 5-point Likert scale and covers five main dimensions of abuse: physical abuse, sexual abuse, emotional abuse, physical neglect and emotional neglect.
Day 7

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Age of patients diagnosed with Borderline Personality Disorder
Time Frame: Day 0
In years
Day 0
Age of healthy controls
Time Frame: Day 0
In years
Day 0
Sex of patients diagnosed with Borderline Personality Disorder
Time Frame: Day 0
Male/Female
Day 0
Sex of healthy controls
Time Frame: Day 0
Male/Female
Day 0
Level of education of patients diagnosed with Borderline Personality Disorder
Time Frame: Day 0
The level of education (Primary, Secondary, University, Post-graduate…) will be recorded.
Day 0
Level of education of healthy controls
Time Frame: Day 0
The level of education (Primary, Secondary, University, Post-graduate…) will be recorded.
Day 0
Type of trauma undergone by patients diagnosed with Borderline Personality Disorder
Time Frame: Day 7
The type of trauma undergone (physical or emotional negligence, physical, sexual or emotional abuse) will be recorded.
Day 7
Type of trauma undergone by healthy controls
Time Frame: Day 7
The type of trauma undergone (physical or emotional negligence, physical, sexual or emotional abuse) will be recorded.
Day 7
Contents of the self-defining memory in patients diagnosed with Borderline Personality Disorder
Time Frame: Day 7
The contents of the self-defining memory (traumatic memory, neutral memory, pleasant memory) will be recorded.
Day 7
Contents of the self-defining memory in healthy controls
Time Frame: Day 7
The contents of the self-defining memory (traumatic memory, neutral memory, pleasant memory) will be recorded.
Day 7
Other observations in patients diagnosed with Borderline Personality Disorder
Time Frame: Day 7
Calculated criteria, such as Body Mass Index, based on clinical observations not necessarily found on the case report form may be added to the final database.
Day 7
Other observations in healthy controls
Time Frame: Day 7
Calculated criteria, such as Body Mass Index, based on clinical observations not necessarily found on the case report form may be added to the final database.
Day 7

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jorge LOPEZ-CASTROMAN, Prof., Psychiatric Unit, Nîmes University Hospital, France
  • Study Director: Stéphane RAFFARD, Prof., Montpellier University III, Laboratoire Epsylon, Route de Mende, 34090 Montpellier, France

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2021

Primary Completion (Actual)

July 31, 2022

Study Completion (Actual)

July 31, 2022

Study Registration Dates

First Submitted

June 17, 2021

First Submitted That Met QC Criteria

June 24, 2021

First Posted (Actual)

July 2, 2021

Study Record Updates

Last Update Posted (Estimate)

January 4, 2023

Last Update Submitted That Met QC Criteria

January 2, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • Local/2021/AS-01
  • 2020-A03352-37 (Registry Identifier: N° ID-RCB)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Borderline Personality Disorder

Clinical Trials on Evaluation using the Self-Defining Memory Questionnaire

Subscribe